Table 2 Concomitant medications used during follow-up in the matched cohort.
From: The impact of aspirin on Klebsiella pneumoniae liver abscess in diabetic patients
Aspirin users (n = 31,750) n (%) | Non-users (n = 31,750) n (%) | p value | |
|---|---|---|---|
Clopidogrel | < 0.01 | ||
Non-exposure | 21,308 (67.11) | 29,350 (92.44) | |
1–90 days | 3447 (10.86) | 657 (2.07) | |
> 90 days | 6995 (22.03) | 1743 (5.49) | |
Ticagrelor | < 0.01 | ||
Non-exposure | 30,322 (95.50) | 31,726 (99.92) | |
Yes | 1428 (4.50) | 24 (0.08) | |
Other anti-platelet agents | <0.01 | ||
Non-exposure | 28,641 (90.21) | 30,904 (97.34) | |
Yes | 3109 (9.79) | 846 (2.66) | |
H2-blocker or proton pump inhibitors | < 0.01 | ||
Non-exposure | 11,951 (37.64) | 15,304 (48.20) | |
1–4 days | 1445 (4.55) | 1380 (4.35) | |
5–30 days | 3109 (9.79) | 3334 (10.50) | |
31–90 days | 3652 (11.50) | 3425 (10.79) | |
> 90 days | 11,593 (36.51) | 8307 (26.16) | |
Metformin | < 0.01 | ||
Non-exposure | 4506 (14.19) | 5139 (16.19) | |
1–30 days | 1353 (4.26) | 2090 (6.58) | |
31–90 days | 1527 (4.81) | 2243 (7.06) | |
> 90 days | 24,364 (76.74) | 22,278 (70.17) |
